This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
List/tripsitting: Difference between revisions
>Graham adding distinction of variant and invariant treatments and explanation about why there aren't antidotes listed for stimulants. |
>Graham m Note regarding advisory counsel |
||
| Line 181: | Line 181: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Dealing with stimulant psychosis]]</h4> | <h4 class="media-heading">[[Dealing with stimulant psychosis]]</h4> | ||
* Cautionary note: the combination of being on dopaminergic agonists and attempting to stop their effects with dopaminergic antagonists may result in a life-threatening condition known as [https://en.wikipedia.org/wiki/Neuroleptic_malignant_syndrome neuroleptic malignant syndrome.] | *Cautionary note: the combination of being on dopaminergic agonists and attempting to stop their effects with dopaminergic antagonists may result in a life-threatening condition known as [https://en.wikipedia.org/wiki/Neuroleptic_malignant_syndrome neuroleptic malignant syndrome.] | ||
</li> | </li> | ||
</ul> | </ul> | ||
| Line 193: | Line 193: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[PTSD treatments|PTSD treatment]]</h4> | <h4 class="media-heading">[[PTSD treatments|PTSD treatment]]</h4> | ||
*[[MDMA-AP]] | *[[MDMA-AP|MDMA Therapy]] | ||
**Note: proposed paradigms have been advised against implementation due to methodological problems. | |||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||